These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 2478511)

  • 1. Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease.
    Yahalom J; Gulati S; Shank B; Clarkson B; Fuks Z
    Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):915-22. PubMed ID: 2478511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow transplantation for refractory or relapsed Hodgkin's disease: the Memorial Sloan-Kettering Cancer Center experience using high-dose chemotherapy with or without hyperfractionated accelerated total lymphoid irradiation.
    Yahalom J; Gulati S
    Ann Oncol; 1991 Feb; 2 Suppl 2():67-71. PubMed ID: 2049322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
    Carella AM; Congiu AM; Gaozza E; Mazza P; Ricci P; Visani G; Meloni G; Cimino G; Mangoni L; Coser P
    J Clin Oncol; 1988 Sep; 6(9):1411-6. PubMed ID: 2458439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease.
    Yahalom J; Gulati SC; Toia M; Maslak P; McCarron EG; O'Brien JP; Portlock CS; Straus DJ; Phillips J; Fuks Z
    J Clin Oncol; 1993 Jun; 11(6):1062-70. PubMed ID: 8501492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
    Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
    Reece DE; Barnett MJ; Shepherd JD; Hogge DE; Klasa RJ; Nantel SH; Sutherland HJ; Klingemann HG; Fairey RN; Voss NJ
    Blood; 1995 Jul; 86(2):451-6. PubMed ID: 7541661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.
    Fermé C; Lepage E; Brice P; D'Agay MF; Fermand JP; Castaigne S; Frija J; Miot C; Marty M; Gisselbrecht C
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):397-405. PubMed ID: 7685749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intensive therapy with autotransplantation for high-risk Hodgkin's disease.
    Moreau P; Milpied N; Mechinaud-Lacroix F; Mahe B; Rapp MJ; Le Tortorec S; Bourdin S; Dupas B; Harousseau JL
    Leuk Lymphoma; 1993 Dec; 12(1-2):51-8. PubMed ID: 7512854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone marrow transplantation in Hodgkin's disease.
    Dumont J; Teillet F
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):531-8. PubMed ID: 2419958
    [No Abstract]   [Full Text] [Related]  

  • 10. Allogeneic marrow transplantation for refractory Hodgkin's disease.
    Phillips GL; Reece DE; Barnett MJ; Connors JM; Fay JW; Herzig GP; Herzig RH; Klingemann HG; Shepherd JD; Wolff SN
    J Clin Oncol; 1989 Aug; 7(8):1039-45. PubMed ID: 2474058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
    Oncology (Williston Park); 1996 Apr; 10(4):593-4. PubMed ID: 8723294
    [No Abstract]   [Full Text] [Related]  

  • 12. Conventional salvage therapy for Hodgkin's lymphoma.
    Pfreundschuh M; Schaadt M; Diehl V
    Recent Results Cancer Res; 1989; 117():225-32. PubMed ID: 2481331
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
    Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger KH; Rühl U
    Leuk Lymphoma; 1994 Jun; 14(1-2):79-89. PubMed ID: 7522721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.
    Bonadonna G; Santoro A; Gianni AM; Viviani S; Siena S; Bregni M; Zucali R; Lombardi F; Bonfante V; Gianni L
    Ann Oncol; 1991 Jan; 2 Suppl 1():9-16. PubMed ID: 1710489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].
    Gisselbrecht C; Lepage E; Brice P; Trédaniel J; Gerota I
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):131-4. PubMed ID: 2455276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
    J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.
    Carella AM; Carlier P; Congiu A; Occhini D; Nati S; Santini G; Pierluigi D; Giordano D; Bacigalupo A; Damasio E
    Bone Marrow Transplant; 1991 Aug; 8(2):99-103. PubMed ID: 1718517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.
    Gianni AM; Siena S; Bregni M; Lombardi F; Gandola L; Di Nicola M; Magni M; Peccatori F; Valagussa P; Bonadonna G
    Ann Oncol; 1993 Dec; 4(10):889-91. PubMed ID: 7509620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potential.
    Buzaid AC; Lippman SM; Miller TP
    Am J Med; 1987 Sep; 83(3):523-32. PubMed ID: 2444105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.